Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression.
Saved in:
| Title: | Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression. |
|---|---|
| Authors: | Wachsmuth LP; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute (NCI)., Patterson MT; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute (NCI)., Eckhaus MA; Division of Veterinary Resources, Office of Research Services., Venzon DJ; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Gress RE; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute (NCI)., Kanakry CG; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute (NCI). |
| Source: | The Journal of clinical investigation [J Clin Invest] 2019 Mar 26; Vol. 129 (6), pp. 2357-2373. Date of Electronic Publication: 2019 Mar 26. |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1558-8238 |
|---|---|
| DOI: | 10.1172/JCI124218 |
